Table 1 Comparison of results of RT-qPCR and FISH methods used in assessment of ROS1 rearrangements.

From: Crizotinib efficacy in advanced non-squamous NSCLC patients with ALK or ROS1 rearrangement

 

Number of cases

RT PCR positive

RT PCR negative

FISH positive

6

3

FISH negative

3

86